NeuroScientific Biopharmaceuticals is transferring its patented tech to one of Australia’s most experienced stem cell manufacturers to scale up production.

Sarepta (NASDAQ:SRPT) stock, Replimune (NASDAQ:REPL) stock and Capricor (CAPR) stock surge as FDA's biologics head exits abruptly. Read more here.

Lab grown models of embryos, made from clusters of stem cells, are getting increasingly complex. Ethicists, regulators and ...

Researchers at the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) have uncovered the ...

Scientists at Indiana University School of Medicine have identified a new approach that could transform treatment for acute ...

A soft FDA, state laws permitting non-FDA-approved biologics, and a country full of stem cell clinics could be a dangerous combination.

Orthopedic non-invasive stem cell therapy regenerates damaged tissue rather than just improving symptoms. Autologous stem cell therapy uses cells from your own body, minimizing rejection risks ...

What makes Gallant's approach different is that its therapy is allogeneic, meaning it leverages uterine-derived mesenchymal stem cells from a single donor animal of the same species, enabling the ...

The adult brain still carries stem cells that grow, divide, and eventually become new mature neurons.

Audible sound can affect gene activity in mouse cells, boosting the attachment of muscle precursors to surrounding tissue and decreasing fat accumulation ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts for therapeutic applications.